MedPath

A study to see effect of Repetitive Transcranial Magnetic Stimulation (rTMS) in improving response in drug resistant OCD patients

Phase 4
Not yet recruiting
Conditions
Health Condition 1: F422- Mixed obsessional thoughts and acts
Registration Number
CTRI/2024/03/063716
Lead Sponsor
Dept of Psychiatry RNT Medical College and MB GOVERNMENT HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Response failure to previous or current use of medication or psychotherapy ( response failure was defined as scores more than 16 at Y BOCS despite atleast two SSRI trials of adequate dose and duration)

2. Stable medication regimen 8- 10 weeks before the intervention and unchanged during the treatment (4-6weeks)

Exclusion Criteria

1. Previous treatment with electroconvulsive therapy, and presence or history of psychosis, substance abuse, suicide attempt and or active suicide ideation, neurological disorder, epilepsy, seizures, and head injury or loss of consciousness

2. According to the safety criteria for rTMS, patients with implanted devices, metal bodies, cardiac arrhythmia, unstable medical conditions, or pregnancy, were also excluded.

3. Patients diagnosed with any other comorbid psychiatric illness except depression and anxiety

4. Patients diagnosed with any other chronic physical illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe the Effect of repetitive transcranial magnetic stimulation in YBOCS score in patients of pharmaco-resistant OCDTimepoint: After 25th session of rTMS
Secondary Outcome Measures
NameTimeMethod
Changes in Y BOCS , HAM-A and HAM-D scoresTimepoint: After 10th , 15th and 20th session of rTMS
© Copyright 2025. All Rights Reserved by MedPath